CASR and breast carcinoma: The CaSR has more recently been studied as a hypothetical predictive marker for skeletal metastases in breast carcinoma, and it was shown that in patients with advanced, metastatic breast cancer, CaSR expression was higher in those with skeletal metastases [11].